Although the mechanism underlying LCN2-mediated chemo resistance has not yet been elucidated, Leung et al indicated that pancreatic cancer cells that weakly expressed LCN2 had higher levels of cleaved caspase 3[43]. The gene discussed is CASP3; the disease is familial pancreatic carcinoma.